These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27023129)

  • 41. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
    Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
    J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RP-LC Method Development and Validation for Dasatinib Forced Degradation Study: Isolation and Structural Characterization by NMR and HRMS.
    Kavitapu DR; Murty JNSRC; Maruthapillai A; Senadi GC; Mahapatra S
    J Chromatogr Sci; 2024 Apr; 62(4):347-355. PubMed ID: 37340779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study of forced decomposition behavior of lamivudine using LC, LC-MS/TOF and MS(n).
    Bedse G; Kumar V; Singh S
    J Pharm Biomed Anal; 2009 Jan; 49(1):55-63. PubMed ID: 19022602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of stress degradation products of fosinopril by using LC-MS/TOF, MS(n) and on-line H/D exchange.
    Narayanam M; Singh S
    J Pharm Biomed Anal; 2014 Apr; 92():135-43. PubMed ID: 24518132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of four new photodegradation products of hydroxychloroquine through LC-PDA, ESI-MSn and LC-MS-TOF studies.
    Saini B; Bansal G
    J Pharm Biomed Anal; 2013 Oct; 84():224-31. PubMed ID: 23850938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural elucidation of two novel degradants of lurasidone and their formation mechanisms under free radical-mediated oxidative and photolytic conditions via liquid chromatography-photodiode array/ultraviolet-tandem mass spectrometry and one-dimensional/two-dimensional nuclear magnetic resonance spectroscopy.
    Wang KC; Guo Q; Kuang Z; Jin J; Li D; Chen W; Zhu W; Li M
    J Mass Spectrom; 2022 Jul; 57(7):e4871. PubMed ID: 35739062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Profiling degradants of paclitaxel using liquid chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry substructural techniques.
    Volk KJ; Hill SE; Kerns EH; Lee MS
    J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(1):99-115. PubMed ID: 9300914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation and structure determination of oxidative degradation products of atorvastatin.
    Kracun M; Kocijan A; Bastarda A; Grahek R; Plavec J; Kocjan D
    J Pharm Biomed Anal; 2009 Dec; 50(5):729-36. PubMed ID: 19615842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid identification of new minor chemical constituents from Smilacis Glabrae Rhizoma by combined use of UHPLC-Q-TOF-MS, preparative HPLC and UHPLC-SPE-NMR-MS techniques.
    Gu WY; Li N; Leung EL; Zhou H; Yao XJ; Liu L; Wu JL
    Phytochem Anal; 2015; 26(6):428-35. PubMed ID: 26183111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural elucidation of degradation products of a benzopyridooxathiazepine under stress conditions using electrospray orbitrap mass spectrometry - study of degradation kinetic.
    Lecoeur M; Vérones V; Vaccher C; Bonte JP; Lebegue N; Goossens JF
    Eur J Pharm Sci; 2012 Apr; 45(5):559-69. PubMed ID: 22207039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comprehensive study to identify and characterize major degradation products of Ivermectin drug substance including its degradation pathways using LC-HRMS and NMR.
    Adhikari S; Rustum AM
    J Pharm Biomed Anal; 2022 May; 214():114730. PubMed ID: 35334396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and validation of a stability-indicating assay including the isolation and characterization of degradation products of metaxalone by LC-MS.
    Rao RN; Farah H; Sahu PK; Janarthan M; Naidu ChG
    Biomed Chromatogr; 2013 Dec; 27(12):1733-40. PubMed ID: 23881540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of stress degradation products of nintedanib by UPLC, UHPLC-Q-TOF/MS/MS and NMR: Evidence of a degradation product with a structure alert for mutagenicity.
    Dhiman V; Balhara A; Singh S; Tiwari S; Gananadhamu S; Talluri MVNK
    J Pharm Biomed Anal; 2021 May; 199():114037. PubMed ID: 33836462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification and characterization of urapidil stress degradation products by LC-Q-TOF-MS and NMR: Toxicity prediction of degradation products.
    Velip L; Dhiman V; Kushwah BS; Golla VM; Gananadhamu S
    J Pharm Biomed Anal; 2022 Mar; 211():114612. PubMed ID: 35101803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of forced degradation products of tamsulosin using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Namdev D; Borkar RM; Raju B; Kalariya PD; Rahangdale VT; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2014 Jan; 88():245-55. PubMed ID: 24083958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparative isolation and high-resolution mass identification of 10 stressed study degradants of nicorandil tablets.
    Prakash L; Malipeddi H; Subbaiah BV
    J Chromatogr Sci; 2015 Jan; 53(1):122-6. PubMed ID: 24837014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Forced degradation study of racecadotril: Effect of co-solvent, characterization of degradation products by UHPLC-Q-TOF-MS/MS, NMR and cytotoxicity assay.
    Chiguru V; Lingesh A; R S; N S
    J Pharm Biomed Anal; 2016 Sep; 128():9-17. PubMed ID: 27209450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigating Betrixaban Maleate drug degradation profiles, isolation and characterization of unknown degradation products by mass-triggered preparative HPLC, HRMS, and NMR.
    Surukonti SR; Manabolu Surya SB; Katari NK; Yerla RR
    J Pharm Biomed Anal; 2023 Oct; 235():115643. PubMed ID: 37633165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and structural elucidation of three new tadalafil analogues found in a dietary supplement.
    Lee JH; Mandava S; Baek SY; Lee YM
    J Pharm Biomed Anal; 2016 May; 123():1-9. PubMed ID: 26855379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.